pfizer - Search News

Head of Pfizer booed by Trump supporters

Newsweek on MSN · 3h

Trump Introducing Pfizer CEO Sparks Loud Booing Inside White House

A study by KFF found that one in four Republican parents now say they've skipped or delayed some childhood vaccines as of January 2025.

Latin Times on MSN · 17h

Pfizer Exec Booed During White House Appearance as Trump Calls Pharma Head 'Great Businessman'

President Donald Trump's introduction of a Pfizer executive at the White House Wednesday was met with a roar of boos from the crowd.

Hosted on MSN · 17h

Video: Head of Pfizer booed by Trump supporters

Head of Pfizer booed by Trump supporters At a Black History Month reception in Washington, DC, Trump shouted out the head of Pfizer, Albert Bourla, who was met with relentless booing. #news #trump #pfizer #politics #blackhistorymonth #washingtondc Daily Mail Website: Daily Mail Facebook: Daily Mail IG: Daily Mail

Irish Star on MSN · 18h

Trump giggles as White House crowd brutally boos head of Pfizer being introduced

The CEO of Pfizer was brutally booed at a press conference Donald Trump held in the White House in commemoration of Black History Month in an awkward moment that involved several similar introductions

Pfizer, Haemophilia B and gene therapy

Hosted on MSN · 4h

Pfizer stops commercialization of hemophilia gene therapy Beqvez

Pfizer said on Thursday it will stop global development and commercialization of its hemophilia gene therapy, Beqvez, citing soft demand from patients and their doctors. Beqvez is a one-time therapy that was approved in the U.

FiercePharma · 1h

Pfizer discontinues hemophilia treatment Beqvez, emptying its gene therapy portfolio

Pfizer is pulling further away from the gene therapy field with its decision to discontinue hemophilia product Beqvez. | Pfizer is pulling further away from the gene therapy field with its decision to discontinue hemophilia B product Beqvez.

Pfizer Axes Beqvez Worldwide, Pivoting Away From Gene Therapy for Hemophilia

The move comes weeks after Pfizer terminated its partnership with Sangamo Therapeutics for another hemophilia gene therapy.

An awkward moment for Pfizer’s Bourla in Washington

The future of the CDC’s vaccine advisory committee seems uncertain: A scheduled February meeting for the ACIP, which advises ...

2d

Why Pfizer's Stock Price Isn't Reflecting Its True Value

Pfizer's strong Q4 2024 results showcase growth in cancer drugs and Vyndaqel sales. Learn why PFE stock is a top pick for ...

8d

Are Investors Being Too Paranoid About Pfizer Stock?

All this negativity, however, does open up an opportunity for investors to buy the stock at a discount. Despite being a top ...

Pharmalittle: We’re reading about RFK Jr. targeting CDC and FDA advisers, a Pfizer gene therapy, and more

HHS Secretary Robert F. Kennedy Jr. is preparing to remove committee members who advise the government on vaccine approvals ...

2d

Pfizer Stock's Upside Got Bigger

Pfizer's robust R&D pipeline is expected to drive future growth and offset patent expirations. Read why I maintain my buy ...

Pfizer inks deal with Mylan Pharma to market Ativan and Pacitane in India

Mylan, which has an established presence in the central nervous system therapy segment, is expected to leverage its network ...

2don MSN

Pfizer CEO Albert Bourla: Focusing on opportunities outside of vaccines with RFK Jr.

Albert Bourla, Pfizer CEO, joins CNBC's Angelica Peebles and 'Closing Bell Overtime' to talk the impact of tariffs, Pfizer's ...

3hon MSN

Is Pfizer Inc. (PFE) the Best Non-Tech Stock to Buy Now for Long Term?

We recently compiled a list of the 10 Best Non-Tech Stocks to Buy Now for Long Term. In this article, we are going to take a ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results